0001209191-20-042488.txt : 20200715
0001209191-20-042488.hdr.sgml : 20200715
20200715164133
ACCESSION NUMBER: 0001209191-20-042488
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200713
FILED AS OF DATE: 20200715
DATE AS OF CHANGE: 20200715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 201029477
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2020-07-13
4
M
0
2125
90.29
A
28963
D
Common Stock
2020-07-13
4
S
0
100
284.28
D
28863
D
Common Stock
2020-07-13
4
S
0
225
285.67
D
28638
D
Common Stock
2020-07-13
4
S
0
100
286.57
D
28538
D
Common Stock
2020-07-13
4
S
0
200
288.57
D
28338
D
Common Stock
2020-07-13
4
S
0
100
290.65
D
28238
D
Common Stock
2020-07-13
4
S
0
200
292.76
D
28038
D
Common Stock
2020-07-13
4
S
0
800
294.57
D
27238
D
Common Stock
2020-07-13
4
S
0
300
295.38
D
26938
D
Common Stock
2020-07-13
4
S
0
100
296.48
D
26838
D
Stock Option (Right to Buy)
90.29
2020-07-13
4
M
0
2125
0.00
D
2026-07-11
Common Stock
2125
0
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $285.67 (range $285.57 to $285.77).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $288.57 (range $288.14 to $288.99).
Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.46 to $293.05).
Open market sales reported on this line occurred at a weighted average price of $294.57 (range $294.15 to $295.02).
Open market sales reported on this line occurred at a weighted average price of $295.38 (range $295.16 to $295.70).
Fully vested.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-07-15